RxDoctor Payments Data

Dixie Stiles, NP

Nurse Practitioner · Jasper, INNPI 1386613941

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 519 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 30 manufacturers reported payments, led by Salix Pharmaceuticals, A Division Of Bausch Health US, LLC at 24.7% of the total. Reporting peaked in 2022 at $4,098 and has fallen 95.2% since, to $195 in 2025. Among nurse practitioner clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$9,317in general payments, 2019–2025

Across 519 payments — averaging $17.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$2K
  • AbbVie$2K
  • Takeda Pharmaceuticals U.S.A., Inc.$1K
  • Johnson & Johnson$605
  • Bristol Myers Squibb$462
  • QOL Medical, LLC$359
  • plus $2K from 24 others

What the payments were for

  • Food & beverage$9,317100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,317 in reported general payments places this provider in the 95th percentile of 2,724 nurse practitioner providers in Indiana.

See all nurse practitioner providers in Indiana

Medicare billing

Part B allowed, 2024
$16,762
Medicare patients
87
Services billed
205

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Omeprazole19$445
Pantoprazole Sodium23$358
Famotidine12$321

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Jasper

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →